The subject of the contract is the successive delivery of drugs used in chemotherapy and drug programs, immunoglobulins, erythropoiesis stimulants and other drugs for the needs of the Multidisciplinary Provincial Hospital in Gorzów Wlkp. Sp. z o. o. at 1 Jana Dekerta Street. A detailed description of the subject of the contract and the estimated quantity is included in Annex 2 to the SWZ - price attachment and the draft contract - Annex 3 to the SWZ.

PERTUZUMABUM, OBINUTUZUMABUM, TOCILIZUMABUM TRASTUZUMABUM EMTASINUM, POLATUZUMAB VEDOTIN, TRASTUZUMABUM OCRELIZUMABUM -in accordance with Appendix No. 2.

NILOTINIBUM, RUXOLITINIBUM, ELTROMBOPAGUM, RIBOCICLIBUM, LAPATINIB, SECUKINUMAB, BROLUCIZUMAB, OFATUMUMAB, NIVOLUMABUM, IPILIMUMABUM, DAROLUTAMIDUM, NETUPITANTUM + PALONOSETRONUM - in accordance with Appendix No. 2.

SUNITINIBUM-in accordance with Appendix No. 2.

SORAFENIBUM-in accordance with Appendix No. 2.

VINORELBINUM - in accordance with Appendix No. 2.

IBRUTINIBUM, DURVALUMABUM, PONESIMODUM, APALUTAMIDE, DARATUMUMABUM, OZANIMODUM, CERTOLIZUMABUM, SOFOSBUVIRUM +VELPATASVIRUM - in accordance with Appendix No. 2.

DOCETAXELUM, DOCETAXELUM, CARBOPLATINUM, CISPLATINUM, DOXORUBICINUM, EPIRUBICIN, ETOPOSIDUM, GEMCITABINUM - in accordance with Appendix No. 2.

OLAPARIBUM, PALIVIZUMABUM, ACALABRUTINIBUM - in accordance with Appendix No. 2.

TOPOTECANUM-in accordance with Appendix No. 2.

PEGYLATED LIPOSOMAL DOXORUBICIN -according to Appendix No. 2.

LAMIVUDINUM-in accordance with Appendix No. 2.

IMATINIBUM-in accordance with Appendix No. 2.

CLADRIBINUM-in accordance with Appendix 2.

BENDAMUSTINUM-in accordance with Appendix No. 2.

CYTARABINUM, METHOTREXATUM, PACLITAXELUM, MITOXANTRONUM - in accordance with Appendix No. 2.

DACARBAZINUM, LEVOFOLINICUM ACID, INTRAVESICAL BCG VACCINE, BLEOMYCIN, HYDROXYCARBAMIDUM - according to Appendix No. 2.

FLUOROURACILUM - in accordance with Appendix No. 2.

TEMOZOLOMIDE - in accordance with Appendix No. 2.

GOLIMUMABUM - in accordance with Appendix No. 2.

IXEKIZUMAB, BARICITINIB, BARICITINIB, ABEMACICLIBUM, RAMUCIRUMABUM - in accordance with Appendix No. 2.

AXITINIBUM, TEMSIROLIMUS, IDARUBICINUM, TOFACITINIB CITRATE - in accordance with Appendix No. 2.

CINACALCETUM HYDROCHLORIDUM - in accordance with Appendix No. 2.

BEVACIZUMAB-in accordance with Appendix No. 2.

VINORELBINUM - in accordance with Appendix No. 2.

CAPECITABINUM - in accordance with Appendix No. 2.

PARICALCITOL - in accordance with Appendix No. 2.

TAFASITAMABUM - in accordance with Appendix No. 2.

MITOMYCINUM - in accordance with Appendix No. 2.

TRABECTEDINUM - in accordance with Appendix No. 2.

ENZALUTAMIDUM - in accordance with Appendix No. 2.

LANREOTIDUM, CABOZANITINIBUM - according to Appendix No. 2.

TRIFLURIDINUM + TIPIRACILUM, PIXANTRONI DIMALES, PEGASPARGASUM - according to Appendix No. 2.

NINTEDANIBUM - in accordance with Appendix No. 2.

OXALIPLATINUM, PEMETREKSEDUM, IRINOTECANI HYDROCHLORIDUM TRIHYDRICUM-in accordance with Appendix No. 2.

TRASTUZUMABUM - in accordance with Appendix No. 2.

DAUNOBLASTIN-in accordance with Appendix No. 2.

MELPHALAN HYDROCHLORIDE - in accordance with Appendix No. 2.

DIMETHYLIS FUMARAS, PEGINTERFERONUM beta - 1a, INTERFERON BETA -1a, NATALIZUMABUM - according to Appendix 2.

RANIBIZUMAB - in accordance with Appendix No. 2.

AFLIBERCEPT - in accordance with Appendix 2.

RASBURICASUM, TERIFLUNOMIDE - in accordance with Appendix No. 2.

AZACITIDINUM - in accordance with Appendix No. 2.

FILGRASTIMUM - in accordance with Appendix No. 2.

PEGINTERFERON ALFA-2 A - in accordance with Appendix No. 2.

CETUXIMABUM, PEMBROLIZUMABUM - in accordance with Appendix No. 2.

ENTECAVIRUM, TENOFOVIRUM DISOPROXILUM, BORTEZOMIBUM - in accordance with Appendix No. 2.

IMMUNOGLOBULIN ANTI-D-in accordance with Appendix No. 2.

GLATIRAMERI ACETAS, ARSENIA TRIOXIDUM, LIPOSOMAL DOXORUBICIN, VINCRISTINUM, ROPEGINTERFERONUM ALFA-2B - in accordance with Appendix No. 2.

BOTULINUM TOXIN TYPE A FREE OF COMPLEXING PROTEINS - in accordance with Appendix No. 2.

BOTULINUM TOXIN TYPE A -in accordance with Appendix No. 2.

ADALIMUMABUM - in accordance with Appendix No. 2.

ETANERCEPTUM-in accordance with Appendix No. 2.

ONDANSETRON, ONDANSETRONUM, POSACONAZOLUM, FLUDARABINI PHOSPHAS, ANAGRELIDUM, MELPHALANUM, CHLORAMBUCILUM, ABIRATERONI ACETATAS, LENALIDOMIDUM, ZOLEDRONICUM ACID, MESNUM -in accordance with Annex 2.

ROMIPLOSTIM, CARFILZOMIB, DARBEPOETIN - according to Appendix No. 2.

IMMUNOGLOBULIN - in accordance with Annex 2.

CYCLOPHOSPHAMIDUM, IFOSFAMIDUM - in accordance with Appendix No. 2.

10% Human immunoglobulin - according to Appendix No. 2. For the period of the contract, the Ordering Party requires the free lending of 8 pumps (with the possibility of increase) for the administration of the preparation.

EPOETINUM ALFA - in accordance with Appendix 2.

BRENTUXIMABUM VEDOTINUM, IXAZOMIBUM - in accordance with Appendix No. 2.

CABAZITAXEL, FULVESTRANTUM preparation for storage outside the refrigerator - according to Appendix No. 2.

VENETOCLAXUM, GLECAPREVIRUM + PIBRENTASVIRUM - in accordance with Annex 2.

POMALIDOMIDUM, FEDRATINIBUM, PACLITAXELUM ALBUMINATUM, AZACITIDINE, TRETINOINUM, DAUNORUBICINI HYDROCHLORIDUM + CYTARABINUM - in accordance with Appendix No. 2.

KETAMINE - in accordance with Appendix No. 2.

ACETYLCYSTEINE, SOTALOL, FERRUM, LORATADINUM, KETOPROFENUM - in accordance with Annex 2.

WATER FOR CLOSED OXYGEN HUMIDIFICATION SYSTEM - in accordance with Appendix No. 2.

ETAMSYLATE, PHOSPHOLIPIDS, TRANEXAMIC ACD, DROTAVERINE, OXYBUTYNIN, BETAXOLOL HYDROCHLORIDE, TRANEXAMIC ACD, REMIFENTANILUM, FLUPENTISOLUM, ZUCLOPENTHIXOLUM, IMMUNOGLOBULINA ANTY- D, LURASIDONE -zgodnie z załącznikiem nr 2.

ANAGRELIDUM-in accordance with Appendix No. 2.

DASATINIBUM - in accordance with Appendix No. 2.

BORTEZOMIB - in accordance with Appendix No. 2.